Galectin Therapeutics shares owned by Raymond James Financial
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Raymond James Financial
from 13F filings
Historical chart of Raymond James Financial investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Raymond James Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $57k | 14k | 4.16 |
| 2025-06-30 | $22k | 11k | 2.11 |
| 2025-03-31 | $14k | 12k | 1.22 |
| 2024-12-31 | $15k | 12k | 1.29 |